Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Beck

Anatomic Pathology Boston, MA Medical Doctor

NPI 1639366891 CMS profile 580565

330 Brookline Ave, Department Of Pathology, Boston, MA 02215

Open in the dashboard

General payments

$17,353

39 records reported · program years 2019–2025

Research payments

$903

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Andrew Beck of Boston, MA is reported in the CMS Open Payments database as having received $17,353 across 39 general payments and $903 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Anatomic Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,471 12
2023 Research $903 2
2019 General $5,882 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Beck
  • Anatomic Pathology median
  • Middle half of Anatomic Pathology
  • National median

In program year 2025, general payments to Andrew Beck were reported at $11,471. Among 419 Anatomic Pathology profiles paid that year, the median was $110 and the middle half received between $28 and $974.

Show as a table
Year Andrew Beck Anatomic Pathology median Middle half National median
2019 $5,882 $112 $31–$404 $163
2020 $0 $185 $25–$4,265 $114
2021 $0 $121 $24–$2,629 $132
2022 $0 $121 $31–$1,816 $149
2023 $0 $96 $28–$1,008 $160
2024 $0 $103 $28–$1,069 $164
2025 $11,471 $110 $28–$974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $11,471 12 payments
  2. Gilead Sciences, Inc. $2,455 19 payments
  3. AstraZeneca UK Limited $1,887 2 payments
  4. Ventana Medical Systems, Inc. $1,539 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $9,000 1 payment
  2. Travel and Lodging $4,618 13 payments
  3. Consulting Fee $1,838 1 payment
  4. Food and Beverage $1,461 23 payments
  5. Education $436 1 payment
Products named General payments · program years 2019–2025
  1. ALINITY $9,096 2 payments
  2. Architect $2,375 10 payments
  3. VENTANA RESEARCH & DEVELOPMENT $1,539 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. F. Hoffmann-La Roche AG $903 2 payments

Records

41 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anatomic Pathology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record